AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2025

Aug 19, 2025

34129_dirs_2025-08-19_2eaa46ef-2b54-4e17-b7f4-68e4a5228aa8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2025-08-15

Reporting Person: Spitznagel Thomas (Sr VP, Technical Ops)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-15	Employee Stock Option (right to buy)	$1.58	A	30000	Acquired	2035-08-15	Common Stock (30000)	Direct

Footnotes

F1: 25% of the options will vest and became exercisable one year after the grant date and the remaining 75% will vest in 12 substantially equal quarterly installments thereafter.